1. Home
  2. |Insights
  3. |Change is Coming: Current and Proposed Institutional Reform in Competition Law and The Path Forward

Change is Coming: Current and Proposed Institutional Reform in Competition Law and The Path Forward

Webinar | 06.29.21, 4:00 AM EDT - 5:30 AM EDT

Register

Please join us for this year’s virtual Annual EU Competition Law Conference, co-hosted by Crowell & Moring and King’s College. Given major proposed and existing legislative reforms in competition law across the globe, we will explore how these reforms are being or can be practically implemented in a panel discussion, followed by a fireside chat and Q&A session. Topics include:


  • Current and Proposed Legislation in the EU
  • The Impact of Brexit
  • Policy & Institutional Reform
  • Implications for Industry & Businesses
Speakers Include:

Amelia Fletcher, Professor of Competition Policy, Norwich Business School; Professor, ESRC Centre for Competition Policy, University of East Anglia; and Non-Executive Director, Competition and Markets Authority

Sarah Cardell, General Counsel, UK Competition and Markets Authority (CMA)

Thomas Deisenhofer, Principal Adviser, Economic ex post evaluation, DG Competition, European Commission

Dr. Justus Haucap, Professor of Economics, Düsseldorf Institute for Competition Economics

Andrew I. Gavil, Professor, Howard University School of Law; and Senior of Counsel, Crowell & Moring LLP

Renato Nazzini, Professor of Law, King’s College London

William E. Kovacic, Global Competition Professor of Law and Policy; Director, George Washington University Competition Law Center; and Non-Executive Director, Competition and Markets Authority

Karel Bourgeois, Partner, Crowell & Moring LLP

Peter Broadhurst, Partner, Crowell & Moring LLP

For more information, please visit these areas: Antitrust and Competition — Brussels Practice, Brussels Practice, Antitrust and Competition — London Practice, Antitrust and Competition

Contact

Participants

Insights

Webinar | 12.10.26

The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations

The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.

View All Insights